title: Developing T cell cancer immunotherapy in the dog with lymphoma.
abstract: Immunotherapy is not a new concept for veterinary medicine; however, adoptive T cell therapy is a new area of research in humans and canines alike. In humans, T cell therapy has been used against many different tumor histologies, including lymphoma, melanoma, and colon cancer. Although in dogs this approach has currently only been applied to lymphoma, other tumor types are under investigation. There are many different strategies used to take advantage of cell-mediated antitumor properties of T cells. This review will discuss many of the current strategies used in both humans and canines in regards to adoptive T cell therapy.
authors.forename: Colleen M
authors.initials: CM
authors.lastname: O'Connor
authors.forename: Heather
authors.initials: H
authors.lastname: Wilson-Robles
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000276:immunology* / Q000628:therapy*; D004285:Dogs; D016219:Immunotherapy, Adoptive / Q000379:methods / Q000639:trends / Q000662:veterinary*; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy / Q000662:veterinary*; D008228:Lymphoma, Non-Hodgkin; D057805:Pets; D015202:Protein Engineering / Q000379:methods; D011946:Receptors, Antigen / Q000235:genetics; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D011946:Receptors, Antigen
keywords: T cell receptor; adoptive T cell therapy; canine; chimeric antigen receptor; lymphoma